ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$0.39
+0.00 (+0.78%)
As of May 16, 2:37 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +835.9% upside
Low Target $2.40
Average Target $3.65
High Target $4.80
Current Price $0.39
Current
$0.39
Target
$3.65
$2.40 $3.65 avg $4.80
Scenario Analysis
Bear Case
$2.40
515.4%
Low target
Base Case
$3.65
+835.9%
Avg target
Bull Case
$4.80
+1,130.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
Target vs 52W High
$3.65
-95.1% vs high
Next Earnings Report
Jun 1, 2026 · After Market Close
15d
until earnings
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%